Le docteur Knock habite à Wall Street : Les nouvelles cibles de l'industrie pharmaceutique = Doctor Knock lives at Wall Street: The new targets of pharmaceutical industryCATHEBRAS, P.La Revue de médecine interne (Paris). 2003, Vol 24, Num 8, pp 538-541, issn 0248-8663, 4 p.Article

Process analytical technologies in the pharmaceutical industry : the FDA's PAT initiative : Process analytical chemistryHINZ, Dirk C.Analytical and bioanalytical chemistry. 2006, Vol 384, Num 5, pp 1036-1042, 7 p.Article

The American Society for Clinical Pharmacology and Therapeutics and the pharmaceutical industryABRAMS, W. B.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 2, pp 282-286, issn 0009-9236Article

Fortschritte auf dem Gebiet der Arzneimittelentwicklung. XIX = Progrès dans la recherche pharmaceutique. XIX = Progress in the field of drug development XIXDELENK-HEYDENREICH, K; HENKLER, G; KELLER, U et al.Pharmazie. 1986, Vol 41, Num 9, pp 617-626, issn 0031-7144Article

Les ambitions d'Ingérop dans l'ingénierie pharmaceutique : Pharmacie = Ingerop's ambitions in pharmaceutical engineeringSAVOSTIANOFF, Dmitri.Info chimie magazine. 2000, Num 423, pp 102-103, issn 1286-0921Article

Industrie pharmaceutique: logistique de distributionGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2007, Vol AGL1, Num AG5435, issn 1282-9072, AG5435.1-AG5435.18Article

Results from a bench marking survey on cassette dosing practices in the pharmaceutical industryACKERMANN, Bradley L.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 9, pp 1374-1377, issn 1044-0305, 4 p.Article

Logistik und Verfahrenstechnik in der Fabrik 2000 = Logistics and process technology in the factory of the year 2000FINK, M; SIMON, R. W.Pharmazeutische Industrie. 1995, Vol 57, Num 6, pp 507-509, issn 0031-711X, 3 p.Article

Industry and academia in collaboration: the Pfizer experiencePRICE, F. D.Circulation (New York, N.Y.). 1985, Vol 72, Num 2, pp 13-17, issn 0009-7322Article

Strategies for improving drug development in the early phaseGRIGOLEIT, H.-G.Pharmazeutische Industrie. 1984, Vol 46, Num 5, pp 521-525, issn 0031-711XArticle

Information requirements for chemists in the pharmaceutical industryBROWN, H. D.Journal of chemical information and computer sciences. 1984, Vol 24, Num 3, pp 155-158, issn 0095-2338Article

Having the last laugh at big pharmaCOOMBES, Rebecca.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7590, pp 396-397, issn 0959-8146, 2 p.Article

Upping the ante on antibodies : Antibody engineering and manufactureBAKER, Monya.Nature biotechnology. 2005, Vol 23, Num 9, pp 1065-1072, issn 1087-0156, 8 p.Article

Biotechnology and rules governing pharmaceuticals in the european communitySAUER, F.Therapeutic agents produced by genetic engineering: Quo Vadis? Symposium. 1986, pp 197-207Conference Paper

Stratégies de diversification dans le secteur biopharmaceutiqueLE, Philippe; HARA, Liuichi; GANESAN, Balaji et al.Biofutur (Puteaux). 2011, Num 326, pp 60-62, issn 0294-3506, 3 p.Article

Ghosts in the Machine: Comment on SismondoMCHENRY, Leemon.Social studies of science. 2009, Vol 39, Num 6, pp 943-947, issn 0306-3127, 5 p.Article

Industrie pharmaceutique: logistique de distribution. ApplicationsGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2008, Vol AGL1, Num AG5436, issn 1282-9072, AG5436.1-AG5436.10Article

L'échantillonnage dans le contrôle de fabrication des médicamentsKIGER, J.L.LA LETTRE DES NOUVELLES PHARMACEUTIQUES : BULLETIN DE L'ORDRE DES PHARMACIENS. 1981, Num 242, pp 269-384Article

Gouvernance du contrôle de la publicité des médicaments: étude des modalités de sanction des publicités non conformes = Governance of drug advertising control: Assessment of misleading advertising penaltiesCHAKROUN, R.Revue d'épidémiologie et de santé publique. 2013, Vol 61, Num 2, pp 95-104, issn 0398-7620, 10 p.Article

La vitamine marketing: quelques réponses aux mutations actuelles de l'industrie pharmaceutiqueTEMPE, B; DUNAIGRE, T; ROUQUETTE, H et al.1992, 95 p.Book

A PROPOS DE POSTES DE SECURITE DANS L'INDUSTRIE PHARMACEUTIQUEHERVOUET JP.1976; ARCH. MAL. PROF.; FR.; DA. 1976; VOL. 37; NO 3; PP. 256-262; (13EMES. JOURN. NATL. MED. TRAV. II; TOURS; 1974)Conference Paper

Le financement optimal des investissements en ressources humaines: le cas des médicaments dans les pays de l'Afrique subsaharienneKLIMEK, C; ORIVEL, F.sd, 583 p.Thesis

HOW A MARRIAGE WITH BIG PHARMA ENDED IN DIVORCEARIE, Sophie.BMJ (Overseas and retired doctors ed.). 2013, Vol 347, Num 7928, pp 15-16, issn 1759-2151, 2 p.Article

New Product Development with Discrete Event Simulation: Application to Portfolio Management for the Pharmaceutical IndustryPEREZ-ESCOBEDO, J. L; AZZARO-PANTEL, C; PIBOULEAU, L et al.Industrial & engineering chemistry research. 2011, Vol 50, Num 18, pp 10615-10629, issn 0888-5885, 15 p.Article

Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug DiscoveryMILLETTI, Francesca; VULPETTI, Anna.Journal of chemical information and modeling. 2010, Vol 50, Num 6, pp 1062-1074, issn 1549-9596, 13 p.Article